chartexchange

GALT
Galectin Therapeutics Inc.
stockNASDAQ

Market OpenNov 19, 2026 3:19:20 PM EST
2.89USD-3.020%(-0.09)103,971
2.8700Bid2.9100Ask0.0400Spread

GALT Financials

In Q3 FY 2026 (ended ), Galectin Therapeutics Inc. (GALT) reported net income of −$3.53M, operating cash flow of −$2.27M, and assets of $13.01M (filed ).

Loading financial statements…